Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (217)	6/29/2004 8:39:47 PM
From: mopgcw	Read Replies (1) \| Respond to of 566

that is exactly the question. They have just under two years cash at the recent burn rate, about $5/share, and a bit of debt. The VCs have been bailing, but I see no end to their current bail (and not just with RIGL), so I am sitting on my current position. R112 results are expected second half of 2004, so the guidance there is of little help -- August or December?? All the other stuff is way way early, so R112 is a bit of a binary... If it gets to $10 or less, personally I would look to seriously add. If you don't have an existing position, that is a much tougher question. let me know what you think. take care. george